טוען...
A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function
Therapeutic monoclonal antibodies (mAbs) are the fastest growing group of drugs with 11 new antibodies or antibody-drug conjugates approved by the Food and Drug Administration in 2018. Many mAbs require effector function for efficacy, including antibody-dependent cell-mediated cytotoxicity triggered...
שמור ב:
| הוצא לאור ב: | Glycobiology |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109350/ https://ncbi.nlm.nih.gov/pubmed/31822882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/glycob/cwz068 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|